| scholarly article | Q13442814 |
| P2093 | author name string | Radha K Dhiman | |
| Swastik Agrawal | |||
| P2860 | cites work | Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus | Q45355580 |
| Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured? | Q45415587 | ||
| Occult hepatitis C virus infection in type II mixed cryoglobulinaemia | Q45708547 | ||
| Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection | Q45746042 | ||
| Hepatocellular carcinoma downstaging in liver transplantation | Q46666533 | ||
| Immune modulator and antiviral potential of dendritic cells pulsed with both hepatitis B surface antigen and core antigen for treating chronic HBV infection | Q50668689 | ||
| Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. | Q51912888 | ||
| Obliterative portal venopathy: portal hypertension is not always present at diagnosis. | Q53076833 | ||
| Mesenteric venous thrombosis | Q57643484 | ||
| Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation | Q57792485 | ||
| Mesenteric venous thrombosis | Q69949394 | ||
| Acute superior mesenteric venous thrombosis: one disease or two? | Q73555714 | ||
| Screening for hepatocellular carcinoma | Q74027220 | ||
| Mesenteric venous thrombosis | Q77396934 | ||
| Splenectomy for reduction of excessive portal hypertension after adult living-related donor liver transplantation | Q78420308 | ||
| Liver transplantation for severe intrahepatic noncirrhotic portal hypertension | Q81783323 | ||
| Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors | Q84293472 | ||
| Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before | Q84341595 | ||
| Idiopathic non-cirrhotic intrahepatic portal hypertension: common cause of cryptogenic intrahepatic portal hypertension in a Southern Indian tertiary hospital | Q84889319 | ||
| ADAMTS13 deficiency, despite well-compensated liver functions in patients with noncirrhotic portal hypertension | Q87732731 | ||
| Surveillance for hepatocellular carcinoma | Q27690269 | ||
| Mesenteric venous thrombosis | Q28080511 | ||
| Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options | Q28084761 | ||
| Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation | Q28344370 | ||
| Pivotal role of ADAMTS13 function in liver diseases | Q33387741 | ||
| Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency | Q33395323 | ||
| Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study | Q33631372 | ||
| Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver | Q34191623 | ||
| Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review | Q34304174 | ||
| Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation | Q34505935 | ||
| Detection of Hepatocellular Carcinoma with PET/CT: A Prospective Comparison of18F-Fluorocholine and18F-FDG in Patients with Cirrhosis or Chronic Liver Disease | Q34624484 | ||
| Epidemiology of hepatocellular carcinoma in India | Q34825693 | ||
| Designing immune therapy for chronic hepatitis B. | Q34825732 | ||
| Role of surveillance in prevention of hepatocellular carcinoma | Q34826014 | ||
| The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations | Q34826535 | ||
| Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications | Q36280426 | ||
| The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection | Q36368397 | ||
| Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials? | Q36985213 | ||
| Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment | Q37278085 | ||
| Challenges and Outcome of Left-lobe Liver Transplants in Adult Living Donor Liver Transplants | Q37613606 | ||
| Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy | Q38027061 | ||
| Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma | Q38040217 | ||
| Occult hepatitis C virus infection and its relevance in clinical practice | Q38371479 | ||
| Randomized controlled trial of screening for hepatocellular carcinoma | Q39679685 | ||
| Mesenteric venous thrombosis--1911 to 1984. | Q39769853 | ||
| Trends in cancer incidence in esophagus, stomach, colon, rectum and liver in males in India. | Q39844325 | ||
| Therapeutic potential of a combined hepatitis B virus surface and core antigen vaccine in patients with chronic hepatitis B. | Q40706767 | ||
| Excessive portal flow causes graft failure in extremely small-for-size liver transplantation in pigs | Q41809307 | ||
| Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies | Q42980336 | ||
| Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. | Q42989655 | ||
| Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations | Q43032321 | ||
| Diagnostic significance of estimation of serum apolipoprotein A along with alpha-fetoprotein in alcoholic cirrhosis and hepatocellular carcinoma patients | Q43877293 | ||
| Critical graft size and functional recovery in living donor liver transplantation | Q44684085 | ||
| Porcine partial liver transplantation: a novel model of the "small-for-size" liver graft | Q44755719 | ||
| Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India | Q45328614 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 376-379 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | Journal of clinical and experimental hepatology | Q26842378 |
| P1476 | title | Hepatobiliary quiz-12 (2014). | |
| P478 | volume | 4 |
Search more.